Biotech Values

[DewDiligence]

ZY IPOs 18.5M* shares @$31.00:

https://finance.yahoo.com/news/zymergen-announces-pricing-upsized-initial-033100038.html

Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

One of the vaguest corporate descriptions I’ve seen in a while, but the IPO was upsized, so the demand for shares must be strong.

*Assuming exercise of underwriter’s option.